GlassScriptPhysician profile
Bejan Fakouri
NPI 1366490633
$21,370.81
in general payments reported to CMS, 2019-2025
42 companies · $3,487 in 2025
The $3,487 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,471 · 2020: $1,392 · 2021: $1,609 · 2022: $4,748 · 2023: $3,263 · 2024: $3,401 · 2025: $3,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,028 · Travel and Lodging: $1,904 · Education: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,027.87 |
| Travel and Lodging | $1,904.23 |
| Education | $219.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $6,569.83 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $2,468.31 | 2019-2020 | |
| Astellas Pharma US INC | $1,541.64 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $1,492.59 | 2019-2025 | Rezum Generator, Axonics, Advantage System |
| Axonics, INC. | $1,009.27 | 2022-2024 | Bulkamid, Axonics |
| Olympus America INC. | $961.36 | 2022-2025 | Itind System, Soltive |
| Angiodynamics, INC. | $920.09 | 2022-2025 | Nanoknife, Solero |
| Pfizer INC. | $833.22 | 2019-2025 | |
| Coloplast Corp | $809.31 | 2019-2024 | Speedicath |
| Abbvie INC. | $582.92 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $560.84 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $347.03 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $304.38 | 2019-2024 | |
| Myovant Sciences INC. | $301.98 | 2021-2022 | |
| Bluewind Medical | $266.89 | 2024 | Revi |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $266.81 | 2019-2023 | Aveed, Edex, Xiaflex |
| Ferring Pharmaceuticals INC. | $256.84 | 2025 | Adstiladrin |
| Procept Biorobotics Corporation | $152.25 | 2024-2025 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $145.50 | 2024-2025 | Lynparza, Imfinzi |
| Endo USA, INC. | $133.63 | 2024-2025 | Xiaflex |
| Urovant Sciences INC | $132.89 | 2022 | |
| Laborie Medical Technologies Corp. | $131.14 | 2022-2025 | Flowstar |
| Siemens Medical Solutions USA, INC. | $122.34 | 2025 | Varian Cryocare Touch System |
| Healthtronics Stone Solutions, LLC | $110.81 | 2021 | |
| Tolmar, INC. | $108.64 | 2023-2025 | Eligard, Jatenzo |
| Karl Storz Lithotripsy-America | $104.25 | 2020 | |
| Agiliti Surgical, INC. | $103.55 | 2023 | Sonablate |
| Genzyme Corporation | $99.79 | 2019 | |
| Blue Earth Diagnostics | $90.33 | 2024 | |
| Halozyme INC | $75.23 | 2023 | |
| 180 Medical, INC. | $67.08 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Becton, Dickinson and Company | $62.07 | 2022 | |
| Janssen Biotech, INC. | $43.07 | 2024 | Erleada |
| Mission Pharmacal Company | $30.80 | 2022-2023 | Uribel |
| Medtronic, INC. | $27.60 | 2024 | Interstim |
| Immunitybio, INC. | $24.66 | 2025 | |
| Azurity Pharmaceuticals, INC. | $24.44 | 2025 | Azmiro |
| C. R. Bard, INC. & Subsidiaries | $20.29 | 2023 | Bard Urinary Drainage Bag |
| Convatec INC. | $19.79 | 2022 | |
| Antares Pharma, INC. | $16.20 | 2024 | Xyosted |
| Allergan, INC. | $16.08 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bejan Fakouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.